Congenital neuroblastoma in a neonate with isotretinoin embryopathy.

Abstract

We describe a neonate with isotretinoin embryopathy and an incidental finding of congenital neuroblastoma. Diffuse liver metastases led to the decision to provide oncologic therapy followed by tumor resection. Despite the possible need for chronic care related to the comorbidities of the isotretinoin embryopathy and oncologic management, the patient remains disease-free. Because of the uncertain etiology of neuroblastoma, it remains unclear whether exposure to isotretinoin during embryogenesis and fetal development had an oncogenic effect on this patient.

• Authors: Shiley Aguilar, Chrystal Louis, John Hicks, Peter Zage, Heidi Russell
• Journal: Journal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 36 Issue 2 Pg. e75-7 (Mar 2014) ISSN: 1536-3678 [Electronic] United States
• PMID: 23652876 (Publication Type: Case Reports, Journal Article)

Chemical References

• Isotretinoin

Topics

• Abnormalities, Drug-Induced
• Adrenal Gland Neoplasms (complications, congenital, pathology)
• Humans
• Infant, Newborn
• Isotretinoin (adverse effects)
• Neuroblastoma (complications, congenital, pathology)